Provided are methods of predicting or assessing the level of severity of cancer or cancer progression in a patient comprising measuring levels of SET expression in a biological sample from a patient and comparing levels of SET expression to a control sample or standard value. Methods for predicting or evaluating the efficacy of a SET therapeutic and kits comprising at least one reagent for measuring SET protein expression are also provided.
申请公布号
WO2013010140(A2)
申请公布日期
2013.01.17
申请号
WO2012US46792
申请日期
2012.07.13
申请人
COGNOSCI, INC;DUKE UNIVERSITY;VITEK, MICHAEL P.;CHRISTENSEN, DALE J.;WEINBERG, J. BRICE
发明人
VITEK, MICHAEL P.;CHRISTENSEN, DALE J.;WEINBERG, J. BRICE